RxDoctor Payments Data

Lee Cummings, MD

Transplant Surgery · Metairie, LANPI 1548416969

Payments from drug & device makers

What this record shows

This record is dominated by education: $10,000 of the $12,269 with a category attached, or 81.5%. Intuitive Surgical accounts for 88.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $6,000 and has fallen 90.3% since, to $582 in 2025.

$12,269in general payments, 2019–2025

Across 41 payments — averaging $299.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$11K
  • Veloxis Pharmaceuticals, Inc.$425
  • Dilon Technologies, Inc.$328
  • Sanofi-aventis U.S. LLC$146
  • Paragonix Technologies, Inc.$127
  • Ipsen Biopharmaceuticals, Inc$104
  • plus $315 from 8 others
$11,296in research payments, 2019–2025

Across 15 payments — averaging $753.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$7K
  • Shire North American Group Inc$4K

What the payments were for

  • Travel & lodging$4053%
  • Food & beverage$1,86415%
  • Education$10,00082%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few transplant surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$121,873
Medicare patients
127
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →